Biosenta Inc. develops, manufactures, and sells chemical compounds for household and industrial applications in Canada. The company develops True, an anti-microbial, dual-action disinfectant for destroying viruses, bacteria, germs, molds, and fungi. It also manufactures and distributes Tri-Filler, an anti-microbial filler to perform filling and bulking functions. Biosenta Inc. was incorporated in 1986 and is based in Toronto, Canada.…
Biosenta Commences TRUE(TM) Testing with Dynamic Facility Services
Biosenta (CNSX: ZRO) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Household & Personal Products industry, part of the Consumer Defensive sector.
The shares were at 0.0450 CAD on 19 November 2026, down 67.9% over 52 weeks. Its 52-week range is 0.0100 CAD to 0.1400 CAD: the price is 67.9% below the high and 350.0% above the low.
Its market capitalisation is 1.62M CAD.
Biosenta reports return on equity of 24.9% and revenue down 77.1% year over year.
Its debt exceeds its cash by 7.50M CAD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.
No upcoming events tracked.